EUVIMEDEUVIMED entdecken
Crossref

Membrane-Context Screening Identifies a Functionally Active Peptide for Targeted Nanodelivery in Triple-Negative Breast Cancer

Yanan Li, Min Zhang, Qinao Wang, Kai Xiang, Yichen Tian, Jun Ma, Hailin Cong, Bing Yu iD

ACS Nano · 05.11.2026

DOI: 10.1021/acsnano.6c08607 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Nano, online erschienen am 05.11.2026. Verfasst von Yanan Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Materials Science and Engineering, College of Chemistry and Chemical Engineering, Institute of Biomedical Materials and Engineering, Qingd…. Hauptthemen laut MEDLINE: Peptides, Triple Negative Breast Neoplasms, Doxorubicin, Drug Carriers. Die Arbeit nennt 23 Literaturangaben. Gefördert von: Natural Science Foundation of Shandong Province, Science and Technology Planing Project of South District of Qingdao City, National Basic Research Program of China (973 Program).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ligand binding identified during screening does not necessarily translate into improved nanocarrier delivery. Here, we report a membrane-context screening strategy that uses BT-549 cell membrane-functionalized silica microspheres to identify peptide ligands with preserved nanodelivery activity. From a 7-mer combinatorial library, P1 (KFYVSGT) was selected as a membrane-enriched peptide candidate based on its preferential retention by the membrane-functionalized stationary phase relative to bare silica. After conjugation to PEG–PCL micelles, P1 preserved the nanocarrier’s size, charge, morphology, stability, and drug-loading capacity, yet markedly enhanced biological performance. P1-functionalized micelles increased BT-549 cellular uptake by approximately 5-fold and tumor accumulation by about 3-fold in a BT-549 xenograft model. When loaded with doxorubicin, P1 micelles restrained tumor expansion to 1.96-fold of the initial volume, compared with 4.83-fold for nontargeted micelles, with favorable preliminary systemic tolerance. Competitive uptake, energy depletion, peptide-affinity capture, inhibition, colocalization, and docking analyses suggest that P1 activity is associated with a Galectin-1-related membrane environment. This work establishes membrane-context screening as a practical route to function-preserving peptide ligands for targeted nanodelivery.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PeptidesTriple Negative Breast NeoplasmsDoxorubicinDrug CarriersCell MembraneDrug Delivery SystemsHumansAnimalsFemaleMicellesCell Line, TumorMiceSilicon Dioxide

Stichwörter der Autor:innen

galectin-1membrane-context screeningpeptide ligandstargeted nanodeliverytriple-negative breast cancer

Substanzen

PeptidesMicellesDoxorubicinDrug CarriersSilicon Dioxide

Autor:innen und Institutionen

  • College of Materials Science and Engineering, College of Chemistry and Chemical Engineering, Institute of Biomedical Materials and Engineering, Qingdao University, Qingdao266071, China.
  • College of Chemistry, Chemical Engineering and Materials Science, Zaozhuang University, Zaozhuang277160, China.

ORCID-Profile: Bing Yu

Förderung

  • Natural Science Foundation of Shandong Province
  • Science and Technology Planing Project of South District of Qingdao City
  • National Basic Research Program of China (973 Program)
  • National Natural Science Foundation of China (NSFC)
  • Qingdao Science and Technology for People's Benefit Demonstration Project
  • Exploration project of the State Key Laboratory of BioFibers and EcoTextiles of Qingdao University
  • Medical Plus Key Project of Qingdao University

Zitieren

APA

Li, Y., Zhang, M., Wang, Q., Xiang, K., Tian, Y., Ma, J., Cong, H., & Yu, B. (2026). Membrane-Context Screening Identifies a Functionally Active Peptide for Targeted Nanodelivery in Triple-Negative Breast Cancer. ACS Nano. https://doi.org/10.1021/acsnano.6c08607

Vancouver

Li Y, Zhang M, Wang Q, Xiang K, Tian Y, Ma J, et al. Membrane-Context Screening Identifies a Functionally Active Peptide for Targeted Nanodelivery in Triple-Negative Breast Cancer. ACS Nano. 2026. doi:10.1021/acsnano.6c08607

BibTeX
@article{Li2026,
  author = {Li, Yanan and Zhang, Min and Wang, Qinao and Xiang, Kai and Tian, Yichen and Ma, Jun and Cong, Hailin and Yu, Bing},
  title = {Membrane-Context Screening Identifies a Functionally Active Peptide for Targeted Nanodelivery in Triple-Negative Breast Cancer},
  journal = {ACS Nano},
  year = {2026},
  doi = {10.1021/acsnano.6c08607}
}
Kostenlos starten →